Bill Text: IL HR0588 | 2023-2024 | 103rd General Assembly | Introduced
Bill Title: Declares May 5-11, 2024 as Tardive Dyskinesia Awareness Week. Encourages anyone experiencing uncontrollable, abnormal, and repetitive movements to consult their healthcare provider regarding their symptoms.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Passed) 2024-05-25 - Resolution Adopted [HR0588 Detail]
Download: Illinois-2023-HR0588-Introduced.html
| |||||||
| |||||||
1 | HOUSE RESOLUTION | ||||||
2 | WHEREAS, Many people living with serious mental illnesses, | ||||||
3 | including bipolar disorder, major depressive disorder, | ||||||
4 | schizophrenia, and schizoaffective disorder or | ||||||
5 | gastrointestinal disorders such as gastroparesis, upset | ||||||
6 | stomach, nausea, and vomiting, may be treated with medications | ||||||
7 | that work as dopamine receptor blocking agents, including | ||||||
8 | antipsychotics and antiemetics; and
| ||||||
9 | WHEREAS, While ongoing treatment with these medications | ||||||
10 | can be necessary, prolonged use is associated with tardive | ||||||
11 | dyskinesia (TD), an involuntary movement disorder that is | ||||||
12 | characterized by uncontrollable, abnormal, and repetitive | ||||||
13 | movements of the face, torso, limbs, and fingers or toes; and
| ||||||
14 | WHEREAS, Even mild symptoms of TD can impact people | ||||||
15 | physically, socially, and emotionally; and
| ||||||
16 | WHEREAS, It is estimated that TD affects approximately | ||||||
17 | 600,000 people in the United States, and approximately 65 | ||||||
18 | percent of people with TD have not been diagnosed, making it | ||||||
19 | important to raise awareness about the symptoms; and
| ||||||
20 | WHEREAS, It is important that people taking these | ||||||
21 | medications be monitored for TD by a healthcare provider; |
| |||||||
| |||||||
1 | regular screening for TD is recommended by the American | ||||||
2 | Psychiatric Association; and
| ||||||
3 | WHEREAS, Clinical research has led to approval of | ||||||
4 | treatments for adults with TD by the U.S. Food and Drug | ||||||
5 | Administration, and recognition and treatment of TD can make a | ||||||
6 | positive impact in the lives of many people experiencing | ||||||
7 | psychotic and mood disorders; and
| ||||||
8 | WHEREAS, The Illinois House of Representatives can utilize | ||||||
9 | its position to raise awareness of TD among the public and | ||||||
10 | medical community; therefore, be it
| ||||||
11 | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | ||||||
12 | HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | ||||||
13 | we declare May 5-11, 2024 as "Tardive Dyskinesia Awareness | ||||||
14 | Week" in the State of Illinois; and be it further
|